Literature DB >> 18694321

mRNA transfection of CXCR4-GFP fusion--simply generated by PCR-results in efficient migration of primary human mesenchymal stem cells.

Martin F Ryser1, Fernando Ugarte, Sebastian Thieme, Martin Bornhäuser, Angela Roesen-Wolff, Sebastian Brenner.   

Abstract

We present a general, entirely PCR-based strategy to construct mRNAs coding for green fluorescent protein (GFP) fusion proteins from a cDNA pool. We exemplify our approach for the chemokine receptor CXCR4. mRNA transfection of the PCR-generated fusion of CXCR4-GFP into K562 cells or primary mesenchymal stem cells (MSCs) resulted in excellent viability (> 90%) with more than 90% of target cells expressing easily detectable CXCR4-GFP for > 72 h. The fusion protein was localized in the plasma membrane and was rapidly internalized upon incubation with the CXCR4 ligand stromal cell-derived factor-1 (SDF-1). Transwell migration experiments showed significantly increased migration of CXCR4-GFP mRNA-transfected MSCs toward a gradient of SDF-1, demonstrating that mRNA-mediated chemokine receptor overexpression allows for transient initiation of chemotaxis. The presented strategy to construct a PCR-based fluorescent fusion protein can be generally applied to other genes of interest to study their function by simple overexpression and easy detection in primary cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18694321     DOI: 10.1089/ten.tec.2007.0359

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  12 in total

1.  Rapid generation of multiplexed cell cocultures using acoustic droplet ejection followed by aqueous two-phase exclusion patterning.

Authors:  Yu Fang; John P Frampton; Shreya Raghavan; Rahman Sabahi-Kaviani; Gary Luker; Cheri X Deng; Shuichi Takayama
Journal:  Tissue Eng Part C Methods       Date:  2012-04-18       Impact factor: 3.056

Review 2.  The legacy of mRNA engineering: A lineup of pioneers for the Nobel Prize.

Authors:  Miroslaw Janowski; Anna Andrzejewska
Journal:  Mol Ther Nucleic Acids       Date:  2022-07-13       Impact factor: 10.183

3.  Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarction.

Authors:  Katarina Kollar; Matthew M Cook; Kerry Atkinson; Gary Brooke
Journal:  Int J Cell Biol       Date:  2009-07-12

4.  Augmentation of epithelial resistance to invading bacteria by using mRNA transfections.

Authors:  Xianqiong Zou; Brent S Sorenson; Karen F Ross; Mark C Herzberg
Journal:  Infect Immun       Date:  2013-08-12       Impact factor: 3.441

Review 5.  Gene Delivery Approaches for Mesenchymal Stem Cell Therapy: Strategies to Increase Efficiency and Specificity.

Authors:  Gopi Suresh Oggu; Shyama Sasikumar; Nirosha Reddy; Kranthi Kiran Reddy Ella; Ch Mohan Rao; Kiran Kumar Bokara
Journal:  Stem Cell Rev Rep       Date:  2017-12       Impact factor: 6.692

6.  Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy.

Authors:  Sung Keun Kang; Il Seob Shin; Myung Soon Ko; Jung Youn Jo; Jeong Chan Ra
Journal:  Stem Cells Int       Date:  2012-06-13       Impact factor: 5.443

Review 7.  Concise Review: Application of Chemically Modified mRNA in Cell Fate Conversion and Tissue Engineering.

Authors:  Zohreh Sadat Badieyan; Todd Evans
Journal:  Stem Cells Transl Med       Date:  2019-03-19       Impact factor: 6.940

8.  Translation, but not transfection limits clinically relevant, exogenous mRNA based induction of alpha-4 integrin expression on human mesenchymal stem cells.

Authors:  Adam Nowakowski; Anna Andrzejewska; Johannes Boltze; Franziska Nitzsche; Li-Li Cui; Jukka Jolkkonen; Piotr Walczak; Barbara Lukomska; Miroslaw Janowski
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

Review 9.  Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives.

Authors:  Itziar Gómez-Aguado; Julen Rodríguez-Castejón; Mónica Vicente-Pascual; Alicia Rodríguez-Gascón; María Ángeles Solinís; Ana Del Pozo-Rodríguez
Journal:  Nanomaterials (Basel)       Date:  2020-02-20       Impact factor: 5.076

Review 10.  mRNA-Enhanced Cell Therapy and Cardiovascular Regeneration.

Authors:  Palas K Chanda; Roman Sukhovershin; John P Cooke
Journal:  Cells       Date:  2021-01-19       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.